endothelial cell growth kit Search Results


97
ATCC endothelial cell growth kit vegf
Endothelial Cell Growth Kit Vegf, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endothelial cell growth kit vegf/product/ATCC
Average 97 stars, based on 1 article reviews
endothelial cell growth kit vegf - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

94
PromoCell endothelial cell growth medium mv kit
Endothelial Cell Growth Medium Mv Kit, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endothelial cell growth medium mv kit/product/PromoCell
Average 94 stars, based on 1 article reviews
endothelial cell growth medium mv kit - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

96
Cell Applications Inc muscle cell basal medium cell applications
Muscle Cell Basal Medium Cell Applications, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/muscle cell basal medium cell applications/product/Cell Applications Inc
Average 96 stars, based on 1 article reviews
muscle cell basal medium cell applications - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
ATCC endothelial cell growth kit
Endothelial Cell Growth Kit, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endothelial cell growth kit/product/ATCC
Average 96 stars, based on 1 article reviews
endothelial cell growth kit - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
PromoCell cell growth kit
Cell Growth Kit, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell growth kit/product/PromoCell
Average 95 stars, based on 1 article reviews
cell growth kit - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

95
ATCC microvascular endothelial cell growth kit vegf
Microvascular Endothelial Cell Growth Kit Vegf, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microvascular endothelial cell growth kit vegf/product/ATCC
Average 95 stars, based on 1 article reviews
microvascular endothelial cell growth kit vegf - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

94
ATCC microvascular endothelial cell growth kit bbe
Microvascular Endothelial Cell Growth Kit Bbe, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microvascular endothelial cell growth kit bbe/product/ATCC
Average 94 stars, based on 1 article reviews
microvascular endothelial cell growth kit bbe - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
Cusabio human vegf elisa kit
Human Vegf Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human vegf elisa kit/product/Cusabio
Average 93 stars, based on 1 article reviews
human vegf elisa kit - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Cusabio vegf
Cytokines in serum and bone tissue of rats in each group. BMP‐2, <t>VEGF,</t> TGF‐β1 and IL‐10 of 5% PI group are lower than other groups, while IL‐6 is higher than other groups at 1 and 2 weeks. BMP‐2, VEGF, TGF‐β1 and IL‐10 of 2.5% PI group and 0.5 PI group are higher than other groups, while IL‐6 is lower than other groups at 1 and 2 weeks. * p < 0.05. (A) Serum BMP‐2; (B) serum VEGF; (C) serum TGF‐β1; (D) serum IL‐10; (E) serum IL‐6; (F) bone tissue BMP‐2; (G) bone tissue VEGF; (H) bone tissue TGF‐β1; (I) bone tissue IL‐10; (J) bone tissue IL‐6.
Vegf, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vegf/product/Cusabio
Average 93 stars, based on 1 article reviews
vegf - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

86
Cusabio vascular endothelial cell growth factor vegf
Cytokines in serum and bone tissue of rats in each group. BMP‐2, <t>VEGF,</t> TGF‐β1 and IL‐10 of 5% PI group are lower than other groups, while IL‐6 is higher than other groups at 1 and 2 weeks. BMP‐2, VEGF, TGF‐β1 and IL‐10 of 2.5% PI group and 0.5 PI group are higher than other groups, while IL‐6 is lower than other groups at 1 and 2 weeks. * p < 0.05. (A) Serum BMP‐2; (B) serum VEGF; (C) serum TGF‐β1; (D) serum IL‐10; (E) serum IL‐6; (F) bone tissue BMP‐2; (G) bone tissue VEGF; (H) bone tissue TGF‐β1; (I) bone tissue IL‐10; (J) bone tissue IL‐6.
Vascular Endothelial Cell Growth Factor Vegf, supplied by Cusabio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vascular endothelial cell growth factor vegf/product/Cusabio
Average 86 stars, based on 1 article reviews
vascular endothelial cell growth factor vegf - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

86
Cusabio vascular endothelial growth factor vegf
Cytokines in serum and bone tissue of rats in each group. BMP‐2, <t>VEGF,</t> TGF‐β1 and IL‐10 of 5% PI group are lower than other groups, while IL‐6 is higher than other groups at 1 and 2 weeks. BMP‐2, VEGF, TGF‐β1 and IL‐10 of 2.5% PI group and 0.5 PI group are higher than other groups, while IL‐6 is lower than other groups at 1 and 2 weeks. * p < 0.05. (A) Serum BMP‐2; (B) serum VEGF; (C) serum TGF‐β1; (D) serum IL‐10; (E) serum IL‐6; (F) bone tissue BMP‐2; (G) bone tissue VEGF; (H) bone tissue TGF‐β1; (I) bone tissue IL‐10; (J) bone tissue IL‐6.
Vascular Endothelial Growth Factor Vegf, supplied by Cusabio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vascular endothelial growth factor vegf/product/Cusabio
Average 86 stars, based on 1 article reviews
vascular endothelial growth factor vegf - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

95
PromoCell endothelial growth media
Substrate stiffness influences BM‐MSC EV production and bioactivity. (a) EV production as quantified by EVs per cell from BM‐MSCs seeded on Sylgard 184 PDMS substrates with different base‐to‐crosslinker ratios. EVs used for this data were from 1 day of collection and isolated and counted separately from the conditioned media from the other 2 days. After media collection, cells were trypsinized and counted ( n = 3). (b) After a scratch was induced, HUVECs were treated with BM‐MSC EVs from the different substrates or growth or basal media, and percent gap closure after 20 h was evaluated via microscopy ( n = 3). (c) HUVECs were resuspended in EV treatments or growth or basal <t>endothelial</t> media, seeded in Matrigel‐coated wells, and tube formation after 3–6 h was quantified by the number of loops that had formed ( n = 3). All values expressed as mean ± SD. All data are representative of at least three independent experiments ( n = 3). Statistical significance was determined by ANOVA; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Endothelial Growth Media, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endothelial growth media/product/PromoCell
Average 95 stars, based on 1 article reviews
endothelial growth media - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


Cytokines in serum and bone tissue of rats in each group. BMP‐2, VEGF, TGF‐β1 and IL‐10 of 5% PI group are lower than other groups, while IL‐6 is higher than other groups at 1 and 2 weeks. BMP‐2, VEGF, TGF‐β1 and IL‐10 of 2.5% PI group and 0.5 PI group are higher than other groups, while IL‐6 is lower than other groups at 1 and 2 weeks. * p < 0.05. (A) Serum BMP‐2; (B) serum VEGF; (C) serum TGF‐β1; (D) serum IL‐10; (E) serum IL‐6; (F) bone tissue BMP‐2; (G) bone tissue VEGF; (H) bone tissue TGF‐β1; (I) bone tissue IL‐10; (J) bone tissue IL‐6.

Journal: Orthopaedic Surgery

Article Title: The Toxicity and Antibacterial Effects of Povidone‐Iodine Irrigation in Fracture Surgery

doi: 10.1111/os.13422

Figure Lengend Snippet: Cytokines in serum and bone tissue of rats in each group. BMP‐2, VEGF, TGF‐β1 and IL‐10 of 5% PI group are lower than other groups, while IL‐6 is higher than other groups at 1 and 2 weeks. BMP‐2, VEGF, TGF‐β1 and IL‐10 of 2.5% PI group and 0.5 PI group are higher than other groups, while IL‐6 is lower than other groups at 1 and 2 weeks. * p < 0.05. (A) Serum BMP‐2; (B) serum VEGF; (C) serum TGF‐β1; (D) serum IL‐10; (E) serum IL‐6; (F) bone tissue BMP‐2; (G) bone tissue VEGF; (H) bone tissue TGF‐β1; (I) bone tissue IL‐10; (J) bone tissue IL‐6.

Article Snippet: RatIL‐6 (CSB‐E04640r), IL‐10 (CSB‐E04595r), BMP‐2 (CSB‐E04508r), VEGF (CSB‐E04757r) and TGF‐β1 (CSB‐E04727r) ELISA kits were purchased from CUSABIO Bioengineering Co. Ltd. (Houston, TX, USA) MRSA (ATCC6538) standard strain and P . aeruginosa (ATCC9027) were provided by the Guangdong Microbial Species Preservation Center (Beijing, China).

Techniques:

Substrate stiffness influences BM‐MSC EV production and bioactivity. (a) EV production as quantified by EVs per cell from BM‐MSCs seeded on Sylgard 184 PDMS substrates with different base‐to‐crosslinker ratios. EVs used for this data were from 1 day of collection and isolated and counted separately from the conditioned media from the other 2 days. After media collection, cells were trypsinized and counted ( n = 3). (b) After a scratch was induced, HUVECs were treated with BM‐MSC EVs from the different substrates or growth or basal media, and percent gap closure after 20 h was evaluated via microscopy ( n = 3). (c) HUVECs were resuspended in EV treatments or growth or basal endothelial media, seeded in Matrigel‐coated wells, and tube formation after 3–6 h was quantified by the number of loops that had formed ( n = 3). All values expressed as mean ± SD. All data are representative of at least three independent experiments ( n = 3). Statistical significance was determined by ANOVA; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

Journal: Bioengineering & Translational Medicine

Article Title: Mesenchymal stem cell extracellular vesicle vascularization bioactivity and production yield are responsive to cell culture substrate stiffness

doi: 10.1002/btm2.10743

Figure Lengend Snippet: Substrate stiffness influences BM‐MSC EV production and bioactivity. (a) EV production as quantified by EVs per cell from BM‐MSCs seeded on Sylgard 184 PDMS substrates with different base‐to‐crosslinker ratios. EVs used for this data were from 1 day of collection and isolated and counted separately from the conditioned media from the other 2 days. After media collection, cells were trypsinized and counted ( n = 3). (b) After a scratch was induced, HUVECs were treated with BM‐MSC EVs from the different substrates or growth or basal media, and percent gap closure after 20 h was evaluated via microscopy ( n = 3). (c) HUVECs were resuspended in EV treatments or growth or basal endothelial media, seeded in Matrigel‐coated wells, and tube formation after 3–6 h was quantified by the number of loops that had formed ( n = 3). All values expressed as mean ± SD. All data are representative of at least three independent experiments ( n = 3). Statistical significance was determined by ANOVA; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

Article Snippet: To measure in vitro angiogenesis, 48‐well plates were coated with 60 μL of growth factor reduced Matrigel (Corning; 356230) and incubated at 37°C for 30 min. P4 HUVECs were then seeded at 35,000 cells/well with either endothelial growth media (PromoCell; C‐22121) with 1% penicillin–streptomycin (positive control), endothelial basal media (negative control), or endothelial basal media (PromoCell; C‐22221) with 0.1% FBS and 1% penicillin–streptomycin with 5E9 EVs/mL.

Techniques: Isolation, Microscopy

Softer 184:527 PDMS substrates improve the angiogenic bioactivity of BM‐MSC EVs. (a) EV production quantified as EV per cell from BM‐MSCs seeded on each substrate made with different ratios of Sylgard 184 and Sylgard 527 ( n = 2). EVs used for this data were from 1 day of collection and isolated and counted separately from the conditioned media from the other 2 days. After media collection, cells were trypsinized and counted. (b) After a scratch was induced, HUVECs were treated with BM‐MSC EVs from the different substrates or growth or basal media, and percent gap closure after 20 h was evaluated via microscopy ( n = 3). (c) HUVECs were resuspended in the different EV treatments or growth or basal endothelial basal media, and tube formation after 3–6 h was quantified by the number of loops that had formed ( n = 3). All values expressed as mean ± SD. Statistical significance was determined by ANOVA; * p < 0.05, ** p < 0.01, and **** p < 0.0001.

Journal: Bioengineering & Translational Medicine

Article Title: Mesenchymal stem cell extracellular vesicle vascularization bioactivity and production yield are responsive to cell culture substrate stiffness

doi: 10.1002/btm2.10743

Figure Lengend Snippet: Softer 184:527 PDMS substrates improve the angiogenic bioactivity of BM‐MSC EVs. (a) EV production quantified as EV per cell from BM‐MSCs seeded on each substrate made with different ratios of Sylgard 184 and Sylgard 527 ( n = 2). EVs used for this data were from 1 day of collection and isolated and counted separately from the conditioned media from the other 2 days. After media collection, cells were trypsinized and counted. (b) After a scratch was induced, HUVECs were treated with BM‐MSC EVs from the different substrates or growth or basal media, and percent gap closure after 20 h was evaluated via microscopy ( n = 3). (c) HUVECs were resuspended in the different EV treatments or growth or basal endothelial basal media, and tube formation after 3–6 h was quantified by the number of loops that had formed ( n = 3). All values expressed as mean ± SD. Statistical significance was determined by ANOVA; * p < 0.05, ** p < 0.01, and **** p < 0.0001.

Article Snippet: To measure in vitro angiogenesis, 48‐well plates were coated with 60 μL of growth factor reduced Matrigel (Corning; 356230) and incubated at 37°C for 30 min. P4 HUVECs were then seeded at 35,000 cells/well with either endothelial growth media (PromoCell; C‐22121) with 1% penicillin–streptomycin (positive control), endothelial basal media (negative control), or endothelial basal media (PromoCell; C‐22221) with 0.1% FBS and 1% penicillin–streptomycin with 5E9 EVs/mL.

Techniques: Isolation, Microscopy